Tag: haemophilia care

Latest articles

AveXis presents new data at 2019 EPNS Congress showing significant therapeutic benefit of Zolgensma

AveXis presents Zolgensma® data at EPNS

AveXis has presented new data on Zolgensma® at the 2019 European Paediatric Neurology Society (EPNS) Congress. The data continue to show the significant therapeutic...
image of a hospital and ambulance showing poor diabetes control costs the NHS £3bn in avoidable treatment

Poor diabetes control costs the NHS £3bn in avoidable treatment

New research finds that poor diabetes control costs the NHS £3bn in potentially avoidable hospital treatment in England. The findings, being presented at this year’s...
Takeda's Takhzyro ®▼ recommended on NHS for hereditary angiodema

Takeda’s Takhzyro®▼ recommended on NHS for hereditary angioedema

Takeda's Takhzyro®▼ recommended on NHS for hereditary angioedema (HAE) in a Final Appraisal Determination (FAD). The health technology appraisal body in England and Wales,...

Popular articles

AveXis presents new data at 2019 EPNS Congress showing significant therapeutic benefit of Zolgensma

Data-driven marketing in pharma: The future is here

Data-driven marketing in pharma, Pamela Walker and Joshua Hull explain why personalisation is the key to unlocking opportunity via pharma digital marketing. In pharma, ‘digital’...
Takeda's Takhzyro ®▼ recommended on NHS for hereditary angiodema

Takeda’s Takhzyro®▼ recommended on NHS for hereditary angioedema

Takeda's Takhzyro®▼ recommended on NHS for hereditary angioedema (HAE) in a Final Appraisal Determination (FAD). The health technology appraisal body in England and Wales,...
SAnofi and Abbott partner to improve diabetes management with technology

Sanofi & Abbott in diabetes management partnership

Sanofi and Abbott have partnered to integrate glucose sensing and insulin delivery technologies to help to further simplify how people with diabetes manage their...
pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
New report on access to cutting edge medicines

New report on access to cutting edge medicines

A new cross-party report is urging the life science community to work together and grasp the opportunity to speed up access to cutting-edge medicines...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription